Trade Mark Journal No.2025/029 18 July 2025
WO0000001861779 (1,5,9,42,44)
Office of origin: United States of America
Date of International Registration:8 May 2025
Date of designation in the UK:
8 May 2025
International priority date claimed: 30 April 2025
(United States of America)
(99163948)
- Class 1
- Chemical and biochemical reagents, assays and kits comprising chemical and biochemical reagents for scientific research use; chemical and biochemical reagents, assays and kits comprising chemical and biochemical reagents for medical research use; chemical and biochemical reagents, assays and kits comprising chemical and biochemical reagents for clinical laboratory use.
- Class 5
- Chemical and biochemical reagents, assays and kits comprising chemical and biochemical reagents for medical and clinical use.
- Class 9
- Downloadable and recorded computer software for collection, analysis, management, and reporting on test data; downloadable and recorded computer software for use in transplantation.
- Class 42
- Software as a Service (SaaS) services featuring computer software for collection, analysis, and management and reporting on test data; Software as a Service (SaaS) services featuring software for use in transplantation.
- Class 44
- Medical and health services relating to dna, genetics and genetic testing; genetic testing for medical purposes; customized healthcare services, namely, the development and provision of customized laboratory, medical, clinical, research, and genetic testing kits.
Omixon Biocomputing Kft.
Representative: Deborah J. Peckham Barclay Damon LLP, 160 Federal Street, Suite 1001, Boston MA 02110, UNITED STATES OF AMERICA